Nitric Oxide Shows Promise For Treatment Of Sickle Cell Anemia
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Nitric Oxide Shows Promise For Treatment Of Sickle Cell Anemia

SAN DIEGO, CA. -- October 20, 1997 -- Reassessing some old theories based on new research could offer help for the thousands of sufferers with sickle cell anemia. Nitric oxide (NO), a gas used successfully to treat certain lung ailments, may have another application -- the unsickling of sickled cells, according to the results of research conducted at the University of Chicago.

The finding, reported at the American Society of Anesthesiologists annual meeting, presents the intriguing possibility NO may be suitable for studies in patients with sickle cell disease, said anesthesiologist William A. McDade, M.D., Ph.D.

Sickle cell disease most frequently occurs in people of African ancestry and is caused by a flaw in the gene that makes hemoglobin, the oxygen-carrying molecule in blood. This flaw makes hemoglobin molecules stick to one another, forming rigid rods within the red blood cells. The disease gets its name from the way in which these rods distort the shape of the cells, causing them to become crescent-shaped. The rigid cells often get stuck in small blood vessels and stop the flow of blood.

This condition depletes oxygen from tissues in other parts of the body causing a number of maladies, including kidney failure, diseases of the retina, strokes, pneumonia and severe pain. Ten percent of African-Americans carry the sickle cell gene and one in 400 has the disease.

A serious, potentially life-threatening complication seen in some sickle cell disease patients is acute sickle chest syndrome. Often, this is caused by the blockage of blood vessels in the lungs or chest.

NO, even in small amounts, causes smooth muscle in the blood vessel wall to relax and the entire vessel to dilate, Dr. McDade said. Anesthesiologists have administered an inhaled form of NO to treat patients with pulmonary hypertension, a condition marked by abnormally high pressure within the arteries and lungs.

"Since nitric oxide is a powerful dilator of blood vessels and some patients with sickle cell disease suffer from episodic congestion of lung blood vessels, nitric oxide might be useful in the treatment of this problem," Dr. McDade said.

In the laboratory, researchers measured the effects of four different concentrations of NO on purified, oxygen-free samples of sickle hemoglobin. Even at the lowest concentrations, NO slowed cell sickling and even promoted the unsickling of sickled cells, Dr. McDade reported. The higher the concentration of NO, the stronger NO's favorable effect, he said.

The discovery counters research conducted more than 20 years ago that suggested NO might actually enhance the formation of sickle cells, Dr. McDade said. "These earlier findings may have led investigators to withhold NO treatment from sickle cell patients for fear of causing more cell sickling," he said.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities